Home > Journals > Giornale Italiano di Dermatologia e Venereologia > Past Issues > Articles online first > Giornale Italiano di Dermatologia e Venereologia 2017 Dec 15

CURRENT ISSUE
 

ARTICLE TOOLS

Publication history
Reprints
Cite this article as

GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA

A Journal on Dermatology and Sexually Transmitted Diseases


Official Journal of the Italian Society of Dermatology and Sexually Transmitted Diseases
Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,311


eTOC

 

Giornale Italiano di Dermatologia e Venereologia 2017 Dec 15

DOI: 10.23736/S0392-0488.17.05770-4

Copyright © 2017 EDIZIONI MINERVA MEDICA

language: English

Matrix metalloproteinase 1: a better biomarker for squamous cell carcinoma by multiple microarray analyses

Li-qiang ZHENG 1, 2, Rui WANG 1, Su-min CHI 3, Cheng-xin LI 1

1 Department of Dermatology, Chinese PLA General Hospital, Beijing, China; 2 Department of Dermatology, the 251st Hospital of Chinese PLA, Zhangjiakou, China; 3 Department of Physiology, Fourth Military Medical University, Xi’an, China


PDF  


BACKGROUND: The present study aimed to validate MMP1 role in the development of squamous cell carcinoma (SCC) by bioinformatics methods.
METHODS: Gene expression data of 10 GSE series (5 HNSCCs and 5 cSCCs) were obtained from the Gene Expression Omnibus (GEO) database and used to identify differentially expressed genes (DEGs).
RESULTS: Higher expression of MMP1 was found rank number one in 9/10 GSE series of SCC. MMP1 was mainly focused on Gene Ontology (GO) terms of collagen catabolic process, extracellular matrix disassembly. The analysis results of Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways mainly involved Rheumatoid arthritis, Bladder cancer and Pathways in cancer. Also, MMP1 was identified as a hub protein in the PPI network by using Cytoscape software. In addition, others MMPs members of family were analysed.
CONCLUSIONS: These results suggested that MMP1 may be pivotal to the transition from normal skin to premalignant lesions to SCC, thus representing a potential therapeutic target gene of diagnosis and prevention in SCC.


KEY WORDS: Matrix metalloproteinase 1 - Squamous cell carcinoma - Biomarker - Bioinformatics

top of page

Publication History

Article first published online: December 15, 2017
Manuscript accepted: December 12, 2017
Manuscript revised: November 8, 2017
Manuscript received: August 27, 2017

Cite this article as

Zheng LQ, Wang R, Chi SM, Li CX. Matrix metalloproteinase 1: a better biomarker for squamous cell carcinoma by multiple microarray analyses. G Ital Dermatol Venereol 2017 Dec 15. DOI: 10.23736/S0392-0488.17.05770-4

Corresponding author e-mail

chengxinderm@163.com